$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
In atrial diseases (e.g., atrial fibrillation [AF]) intracellular Ca2+ signaling is profoundly altered1. While many of the underlying mechanisms of ‘remodeled’ intracellular Ca2+ signaling in AF have been well characterized2,3, the role an altered intracellular sodium concentration ([Na+]i) may play is poorly understood. [Na+]i is an important regulator of intracellular Ca2+. The study of [Na+]i can provide insight into the activation of the sarcolemmal Na+/Ca2+ exchanger (NCX), the behavior of Na+ channels and Na+,K+-ATPase (NKA)4. We have previously shown that high atrial activation rates, as occur during AF, lead to a significant reduction in [Na+]i 1. Previous work has shown an increase in NCX current density (INCX) and protein expression levels in AF3. An increase in the late component of the voltage-dependent Na+ current (INa, late) in isolated atrial myocytes from patients with AF was also reported5. Thus, there is evidence of profound changes in intracellular Na+ homeostasis in AF. Reliable and reproducible measurements of [Na+]i in isolated atrial myocytes are therefore needed to further our understanding of AF pathology. Here, we demonstrate how to reproducibly isolate high quality murine atrial myocytes that are suitable for measurements of [Na+]i. We have focused our optimized atrial cell isolation protocol on murine atrial myocytes because transgenic (TG) mouse models of atrial fibrillation have become a vital part of AF research6. These mice are often only available in limited numbers and the atria are often fibrotic leading to challenges for cell isolation.
In general, [Na+]i in viable cells can be measured with fluorescent indicators7,8, or with different types of microelectrodes9. Microelectrode-based techniques require penetration of the sarcolemmal membrane. This technique is therefore limited to larger cells and is unsuitable for small and narrow atrial myocytes whose cell integrity is easily compromised.
Sodium-binding benzofuran isophthalate (SBFI) is a fluorescent indicator, which undergoes a large wavelength shift upon binding Na+ 7. SBFI is alternatingly excited at 340 nm and 380 nm and emitted fluorescence is collected after passing through an emission filter (510 nm). Ratios of signals at the two excitation wavelengths (F340/380) can cancel out the local path length, dye concentration, and wavelength-independent variations in illumination intensity and detection efficiency. When an in situ calibration using solutions with known sodium concentration ([Na+]) is performed in each cell the F340/380 ratio obtained during the experiment yields precise and sensitive measurements of [Na+]i. As all Na+ indicators, SBFI also displays some affinity for K+. Using the calibration method shown here allows to reliably ‘clamp’ [Na+]i and intracellular potassium concentration ([K+]i) during the calibration process so that [Na+]i can be reliably calibrated even when it is <10% of [K+]i 10.
We introduce a novel EMCCD camera based technique for ratiometric measurements of [Na+]i using SBFI. The EMCCD camera allows, for the first time, simultaneous [Na+]i measurements (and calibration) in multiple cells. This is especially beneficial in an experimental setting where animal numbers are limited (e.g., transgenic mouse models). Typically, [Na+]i measurements using SBFI are performed using a photomultiplier tube (PMT) to collect whole cell epifluorescence1,11. While PMTs offer very good temporal resolution of the fluorescence signal, the spatial resolution is very low and experiments are limited to one cell at a time.
Our novel protocol facilitates highly reproducible and sensitive measurements of [Na+]i. It is optimized for the simultaneous acquisition of changes in [Na+]i in multiple murine atrial myocytes, but is adaptable to many other cell types.